Please login to the form below
PRINCIPLE study
This page shows the latest PRINCIPLE study news and features for those working in and with pharma, biotech and healthcare.
AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients
Results from this study showed that 11.2% of hospitalised COVID-19 patients who received Farxiga experienced an organ failure or died after 30 days of treatment versus 13.8% in ... reasonable doubt because patient outcomes rapidly improved during the
Latest news
-
Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
The study will continue until all remaining patients have completed their follow-up, at which point a full analysis will be completed. ... In January, the PRINCIPLE study also found that the commonly-used antibiotics azithromycin and doxycycline are not
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
PRINCIPLE study evaluated the commonly-used antibiotics in patients aged over 50. ... The UK-based PRINCIPLE study has found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early
-
Amgen/UCB space shuttle test
Researchers will analyse the structure, composition, strength, and cell and molecular nature of the mice's bones from the flight to study the efficacy of the sclerostin antibody in regulating bone ... This proof of principle study will enhance our
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Patient-centricity in improving patient recruitment advertising
A study showed that when individuals have a positive emotional association with a specific brand, they are:. ... them off enrolling onto the study based on this principle.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- GSK and CureVac to advance mRNA COVID-19 and flu vaccine candidates
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
PMHub
Genesis Research
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
